3645 results for «2612»
3645 results
The VitaFlow TAVI system - A new device that delivers exceptional patient outcomes
29 Nov 2022 – From PCR London Valves 2022
In this session, a panel of experts introduce the VitaFlow TAVI system, a good option for patients with complex anatomies. They also present the five-year results of VitaFlow in severe aortic stenosis.
Hot TAVI topics - Cerebral embolic protection
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the latest data concerning cerebral embolic protection (CEP) in TAVI, to find out about currently available and emerging embolic protection devices and to get a better understanding of variations in head and neck vessel anatomy and tips and tricks...
Primary mitral regurgitation: key imaging requirements for diagnosis and procedural planning
27 Nov 2022 – From PCR London Valves 2022
In this session, find out more about the most common types of primary mitral regurgitation and methods for their evaluation, the principal indications for intervention, as well as the available modes of therapy (surgical/transcatheter) and most appropriate choices for individual patients.
Ensuring optimal TAVI outcomes - LIVE case
27 Nov 2022 – From PCR London Valves 2022
A 75-year-old female with diabetes and history of ischemic stroke 5 years ago presents a symptomatic severe aortic valve stenosis in a small annulus.
After pre-dilatation (18 mm balloon), the operators implant an Acurate neo2 23 mm with a sentinel cerebral embolic protection device. Watch them perform...
Hot TAVI topics - Emerging indications
27 Nov 2022 – From PCR London Valves 2022
Consult this session on hot TAVI topics to learn more about the under-treatment problem of patients with aortic valve disease, the rationale behind emerging TAVI indications and ongoing trials, as well as the nuances of patient selection and the key role of cardiac imaging in identifying markers of...
Primary mitral regurgitation: treatment options when the anatomy is complex
27 Nov 2022 – From PCR London Valves 2022
Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.
Twenty years of progress - What we have achieved - LIVE case
27 Nov 2022 – From PCR London Valves 2022
- Part 1: TAVI by axillary access (Live)
An 80-year-old female with peripheral arterial disease presents a symptomatic severe aortic stenosis with small annulus and preserved LV function.
The operators implant, by axillary access, an Evolut pro 26 mm, on general anaesthesia, with predilatation (Balloon 18 mm) and post-dilatation...
Repair vs. replacement for the treatment of tricuspid valve disease
27 Nov 2022 – From PCR London Valves 2022
Watch this session on tricuspid valve disease to learn more about its current modes of treatment (including new and emerging devices), to understand which patients are the best candidates for this procedure and to explore the challenges that may be encountered during it.
TAVI step by step: from femoral puncture to procedural success
27 Nov 2022 – From PCR London Valves 2022
Look at these presentations to get insights into the basics of CT evaluation for TAVI procedural planning, and discover how to optimise every aspect of the TAVI procedure and ensure the best clinical outcomes even in difficult anatomies.
TAVI: emerging evidence
27 Nov 2022 – From PCR London Valves 2022
Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and...
Tricuspid valve interventions in heart failure patients - Treatment optimisation and pre-procedural work-up
27 Nov 2022 – From PCR London Valves 2022
Consult these presentations to learn more about tricuspid valve intervention in heart failure patients, to discover which patients are suitable candidates for this procedure and to appreciate the importance of imaging, haemodynamic assessment, optimised medical and heart rhythm treatment prior to this intervention.
TAVI challenges: session 1
27 Nov 2022 – From PCR London Valves 2022
Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.
TMVR challenges
27 Nov 2022 – From PCR London Valves 2022
Challenges in this session of PCR LV 2022 include hybrid valve implantation for mitral annular calcification, transcatheter double-valve implantation complicated by mitral bioprosthesis migration, and transcatheter transseptal mitral valve implantation. Watch now to find out more!
TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.
CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention
27 Nov 2022 – From PCR London Valves 2022
Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.
Rapid-fire abstracts: session 3
27 Nov 2022 – From PCR London Valves 2022
Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.
Mitral valve in mitral annular calcification (MAC) - Recorded case
27 Nov 2022 – From PCR London Valves 2022
A 53-year-old male with a history of SAVR (Perimount 23) 10 years ago and chest radiotherapy (lymphoma) presents a severe mitral stenosis (MAC) with preserved LV function and impaired RV function.
On sentinel cerebral protection, the operators perform a transseptal puncture with electrifying a non-stiff guide wire,...
Rapid-fire abstracts: session 4
27 Nov 2022 – From PCR London Valves 2022
In this PCR LV 2022 session dedicated to TAVI, take advantage of the 7 abstracts to learn more about the impact of TAVI for pure regurgitation on the severity of concomitant mitral regurgitation, the deformation of transcatheter heart valve and haemodynamics after aortic ViV, and much...
Valve-in-valve TAVI: Session 2
28 Nov 2022 – From PCR London Valves 2022
Consult this session on Valve-in-valve TAVI to discover a selection of cases presented during PCR LV 2022: valve-in-valve TAVR status post ascending aorta and aortic arch replacement, valve-in-valve and endovascular treatment of aortic dissection in a Marfan patient, valve-in-valve TAVR in a freestyle root 25 mm through a severely...
Rapid-fire abstracts: Session 7
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...
